Vismodegib for giant, locally advanced, basal cell carcinoma and its complex position in clinical practice

Fabiënne H J Koekelkoren; Sofie L Roodbergen; Ewout M Baerveldt; Alexander P W M Maat; Dominiek A Monserez; Dirk J Grünhagen; Marc A M Mureau; Ellen R M de Haas; Tamar E C Nijsten; Marlies Wakkee

doi:10.1016/j.jdcr.2018.11.002

Vismodegib for giant, locally advanced, basal cell carcinoma and its complex position in clinical practice

JAAD Case Rep. 2019 Mar 1;5(3):267-270. doi: 10.1016/j.jdcr.2018.11.002. eCollection 2019 Mar.

Affiliations

¹ Department of Dermatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
² Department of Cardiothoracic Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
³ Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
⁴ Department of Surgical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
⁵ Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.

No abstract available

Keywords: BCC, basal cell carcinoma; CT, computed tomography; hedgehog pathway inhibitor; locally advanced basal cell carcinoma; metastatic basal cell carcinoma; vismodegib.

Publication types

Case Reports